Mereo BioPharma gets second Nasdaq notice; extra 180 days to meet $1 bid price

Mereo BioPharma Group plc

Received second Nasdaq notice on Aug 18, 2026; new compliance deadline Feb 16, 2027.
Must close at $1.00+ for 10 consecutive business days to regain compliance.
If not compliant by Feb 16, 2027, Nasdaq will issue delisting notice; company may appeal.
First notice received Feb 17, 2026; initial 180-day period expired Aug 17, 2026.
Company monitoring bid price and considering options to regain compliance.

Featured in Daily 8-K Digest

Selected #7 for 2026-08-19. Read digest

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.